Nautilus Biotechnology (NAUT) Other Non-Current Assets (2020 - 2026)

Nautilus Biotechnology has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $1.2 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.2 million, changed 0.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (changed 0.34% YoY), and the FY2025 annual result was $1.2 million, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $1.2 million for Q1 2026 at Nautilus Biotechnology, roughly flat from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 million in Q2 2023 to a low of $997000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1.2 million (2023), against an average of $1.2 million.
• Across the five-year window, Other Non-Current Assets jumped 77.43% in 2023 and sank 33.3% in 2024, its largest moves.
• Nautilus Biotechnology's Other Non-Current Assets stood at $1.1 million in 2022, then rose by 6.5% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then retreated by 0.34% to $1.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.